Anthem, Inc. (NASDAQ:ANTX – Get Free Report) Director Robin Shane Readnour sold 10,019 shares of the firm’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $6.02, for a total value of $60,314.38. Following the transaction, the director directly owned 557,990 shares in the company, valued at approximately $3,359,099.80. The trade was a 1.76% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Robin Shane Readnour also recently made the following trade(s):
- On Thursday, September 3rd, Robin Shane Readnour sold 6,100 shares of Anthem stock. The stock was sold at an average price of $6.07, for a total value of $37,027.00.
- On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The shares were sold at an average price of $6.01, for a total value of $212,766.02.
Anthem Stock Down 0.7%
Shares of NASDAQ ANTX opened at $5.69 on Friday. The stock has a market cap of $214.74 million, a PE ratio of -5.32 and a beta of -0.99. Anthem, Inc. has a 52-week low of $1.00 and a 52-week high of $7.19. The business has a 50-day moving average price of $5.38 and a 200 day moving average price of $4.47.
Hedge Funds Weigh In On Anthem
Large investors have recently bought and sold shares of the company. Vivo Capital LLC purchased a new stake in shares of Anthem in the first quarter valued at about $10,785,000. Commodore Capital LP purchased a new position in Anthem during the first quarter worth about $7,981,000. Spruce Street Capital LP acquired a new stake in Anthem in the first quarter valued at about $5,576,000. Ally Bridge Group NY LLC acquired a new stake in Anthem in the first quarter valued at about $1,800,000. Finally, Bank of America Corp DE raised its holdings in Anthem by 2.2% in the 1st quarter. Bank of America Corp DE now owns 393,702 shares of the company’s stock valued at $1,346,000 after acquiring an additional 8,390 shares during the last quarter. Hedge funds and other institutional investors own 90.47% of the company’s stock.
Wall Street Analyst Weigh In
ANTX has been the subject of several research reports. Leerink Partners upgraded shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price target for the company in a research report on Thursday, May 14th. Wall Street Zen raised shares of Anthem from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Anthem in a research note on Monday, July 6th. Finally, Guggenheim began coverage on shares of Anthem in a report on Monday, July 20th. They issued a “buy” rating and a $9.00 target price for the company. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $9.00.
Check Out Our Latest Stock Report on Anthem
About Anthem
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.
Featured Articles
- Five stocks we like better than Anthem
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.
